Hero MotoCorp (NSE: HEROMOTOCO) May dispatches rise to 5.7 lakh units as VIDA and exports sharpen growth story
Read More Pharma Industry News Erasca (NASDAQ: ERAS) climbs into ASCO 2026 as pan-RAS thesis gets second wind Erasca lost half its value on an IP challenge and a trial death. Now ASCO 2026 looms, Merck is on board, and traders are positioning before the verdict. byVenkateshMay 27, 2026